<DOC>
	<DOCNO>NCT01139749</DOCNO>
	<brief_summary>Oral isotretinoin gold standard drug treat moderate severe acne . Other indication like seborrhea , seborrheic dermatitis suggest . There risk reversible mucocutaneous side effect , well alteration lipid profile transaminase . The major problem teratogenicity demand pregnancy control treatment begin one month treatment end . Seborrhea seborrheic dermatitis chronic condition characterize oily skin , hair scalp , erythema , desquamation negative impact quality life . This interventional , therapeutic quality life randomize , comparative ( parallel group ) , blind evaluation clinical trial , comprise 50 men woman , age 18 40 . Treatment low-dose oral isotretinoin compare topical anti-seborrheic product evaluate reduction sebaceous secretion colonization affect area yeast Malassezia gender . Efficacy evaluate clinical parameter , well sebum secretion measure application quality life questionnaire . Safety evaluate skin hydration measure , side effect report observation . For subject use oral isotretinoin blood counting , transaminase , lipid profile pregnancy test request selection criterion , day 30 180 . Data submit statistical analysis .</brief_summary>
	<brief_title>Efficacy Safety Low-dose Oral Isotretinoin Seborrhea</brief_title>
	<detailed_description>Oral isotretinoin retinoid control gene expression relate cellular proliferation , differentiation , specific action sebocytes , reducting sebaceous gland size secretion rate . Its bind specific retinoid nuclear receptor weak . It gold standard drug treat moderate severe acne . Other indication suggest : seborrhea , seborrheic dermatitis , rosacea non-melanoma skin cancer prevention . There well know reversible side effect like mucocutaneous - cheilitis , dryness skin , nose eye risk alteration lipid profile transaminase . The major problem teratogenicity demand pregnancy control two different method , treatment begin one month treatment end . Seborrhea seborrheic dermatitis chronic correlate condition characterize oily skin , hair scalp , erythema , desquamation negative impact quality life . Seborrhea common problem , affect 30 % population . Seborrheic dermatitis affect 3 5 % world population , difference gender race . The etiopathogenic factor involve condition : individual susceptibility , elevate sebaceous secretion irritant action product lipophilic yeast Malassezia gender . The treatment usually involve topical use corticosteroid , salicylic acid , ketoconazole , ciclopirox olamine , pimecrolimus tacrolimus . The dermatosis impact quality life evaluate generic specific questionnaire . The used generic questionnaire : '' Dermatology Life Quality Index DLQI '' `` Medical Outcomes Study 36-Item Short-Form Health Survey SF-36 '' . Recently specific questionnaire oily skin name `` Oily Skin Self-Image Questionnaire OSSIQ '' publish . This interventional , therapeutic quality life randomize , comparative ( parallel group ) , blind evaluation clinical trial , comprise 50 men woman , age 18 40 . Treatment low-dose oral isotretinoin ( 20 mg day , every day ) compare topical anti-seborrheic product evaluate reduction sebaceous secretion colonization affect area saprophyte yeast Malassezia gender . Efficacy evaluate clinical parameter , well sebum measure application two quality life questionnaire : SF-36 OSSIQ ( translation validation Brazilian Portuguese ) . Safety evaluate skin hydration measure , side effect report observation . The device Sebumeter Corneometer , Courage &amp; Khazaka , KÃ¶ln , Germain , use . For subject use oral isotretinoin blood counting , transaminase , lipid profile pregnancy test request selection criterion , day 30 180 . Results submit statistical analysis .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<mesh_term>Ciclopirox</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>consent form signature presence seborrhea / seborrheic dermatitis face scalp good health previous treatment oral isotretinoin last 6 month normal laboratorial test : pregnancy test , blood counting , transaminases lipide profile concordance use two anticonceptional method , one month end study difficulty follow study condition pregnancy risk diabetes collagen diseases bone muscle diseases alcohol abuse hypervitaminosis A</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>oral isotretinoin</keyword>
	<keyword>sebaceous secretion</keyword>
	<keyword>seborrhea</keyword>
	<keyword>seborrheic dermatitis</keyword>
	<keyword>quality life</keyword>
	<keyword>Malassezia</keyword>
</DOC>